ALPHA TRIBE

Welcure Drugs & Pharmaceuticals LtdBoard Meeting, 13-11-2025: Board Meeting

13-11-2025 | 05:35 pm

WELCURE's Q2 & H1 FY26 financial results for Sep 30, 2025: Auditors issued a disclaimer of opinion due to insufficient documents for sales, purchases, inventory, loans, receivables, and assets. Management cannot estimate the impact.

No comments yet. Be the first to comment!

All announcements from Welcure Drugs & Pharmaceuticals Ltd